Clinical Evaluation of the Safety and Effectiveness of Heptonica: A Ghanaian Hepatorestorative Polyherbal Product

Table 4

Assessment of Heptonica on haematological parameters.

Haematology	Day 0	Day 28	value
WBC	5.2 (0.2)	5.1 (0.2)	0.191
Lymph #^†	2.1 ± 0.1	2.1 ± 0.1	0.531
Mid #	0.5 (0.0)	0.45 (0.0)	0.156
Gran #	2.8 (0.2)	2.8 (0.2)	0.990
Lymph %	39.6 (1.5)	41.3 (1.5)	0.274
Mid %	9.6 (0.3)	8.8 (0.3)	0.080
Gran %^†	49.4 ± 1.3	50.3 ± 1.5	0.547
Hb^†	13.3 ± 0.3	13.7 ± 0.3	0.002
RBC^†	4.7 ± 0.1	4.6 ± 0.1	0.569
MCV	85.9 (1.2)	87.6 (0.9)	0.029
MCH	29.4 (0.6)	30.8 (0.4)	<0.0001
MCHC	33.4 (0.3)	34.0 (0.4)	0.002
PLT^†	224.6 ± 11.5	231.3 ± 12.2	0.427

Data are presented as median (interquartile range (IQR)) (Wilcoxon matched-pairs signed-rank test); “†” indicates that data were parametric and were compared using paired t-test.  ≤ 0.05 was considered significant when compared to baseline. WBC: white blood cells; lymph: lymphocytes; mid cells: monocytes; granulocytes: basophils, eosinophils, and neutrophils; RBC: red blood cells; Hb: haemoglobin; MCV: mean corpuscular volume; MCH: mean corpuscular haemoglobin; MCHC: mean corpuscular haemoglobin concentration; PLT: platelet.